Chinese Cohort Study of Coronary Heart Disease (CCS-CHD)

Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients

Construction of coronary heart disease cohort of more than 10000 patients in China. Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.

Study Overview

Status

Unknown

Detailed Description

More than 40 hospitals of 16 provinces will enroll patients for this study. The study will include patients with diagnosed coronary heart disease. Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that. Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease. Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire. Physicians will also take a second test on secondary prevention of CHD at that time. Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.

Study Type

Observational

Enrollment (Anticipated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100034
        • Recruiting
        • Peking University First Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Diagnosed coronary heart disease

Description

Inclusion Criteria:

  • Diagnosed coronary heart disease
  • Confirmed by coronary angiography;
  • Diagnosed myocardial infarction;
  • Typical symptom of ischemic chest pain with positive stress test;
  • Willing to sign an inform consent.

Exclusion Criteria

  • Patients won't sign an inform consent or will not comply with the follow up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tao Hong, MD, Peking University First Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Primary Completion (Anticipated)

December 1, 2010

Study Completion (Anticipated)

December 1, 2010

Study Registration Dates

First Submitted

September 2, 2008

First Submitted That Met QC Criteria

September 2, 2008

First Posted (Estimate)

September 3, 2008

Study Record Updates

Last Update Posted (Estimate)

September 3, 2008

Last Update Submitted That Met QC Criteria

September 2, 2008

Last Verified

May 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Heart Diseases

3
Subscribe